Nicole Eggert Says She Has Breast Cancer, ‘Panics’ Over Spread Uncertainty

The former “Baywatch” and “Charles in Charge” star said she is concerned for her 12-year-old daughter amid the actor’s “rough” journey.

The former “Baywatch” and “Charles in Charge” star said she is concerned for her 12-year-old daughter amid the actor’s “rough” journey.
In the 20th century, oil was the resource most likely to spark global conflict. In the 21st, that resource may well be water. As climate change reshapes rainfall, glaciers, and river flows, fresh water—once taken for granted—is becoming a source of growing geopolitical tension. Rivers that sustain millions of people are now at the center…
To kick off Glaucoma Awareness Month in January, experts are setting the record straight on some common myths about what the American Academy of Ophthalmology (AAO) calls the “silent thief of sight.” Approximately three million Americans have glaucoma. Yet only half of them are aware they have the potentially blinding disease, according to the Centers…
It’s the season when many people set New Year’s resolutions for the year ahead, and these goals are often related to physical health. Experts say there’s one big area that many people should focus on when it comes to their well-being: cardiovascular health. “Cardiovascular disease is the number one cause of death in America,” said…
SINGAPORE — Singapore’s latest spike in Covid cases may be starting to peak — but the public needs to stay up to date on vaccinations, Health Minister Ong Ye Kung told CNBC on Thursday. Singapore reported 56,043 Covid cases in the week of Dec. 3 to 9, marking a 75% surge compared to the week…
A drug approved by the FDA over two decades ago for use in medical abortions and miscarriages is at risk of being pulled from the market after a decision by a Trump-appointed federal judge in Texas on Friday. However, a second federal judge in Washington state issued a competing ruling that would prohibit the FDA…
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….